Tredje Ap Fonden Gilead Sciences, Inc. Transaction History

Tredje Ap Fonden

$10.2 Billion
Q2 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$73.27 - $83.09 $386,132 - $437,884	5,270 Added 9.68%	59,687 $4.84 Million
Q1 2023 May 10, 2023	BUY	$77.31 - $88.08 $608,893 - $693,718	7,876 Added 16.92%	54,417 $4.51 Million
Q4 2022 Feb 10, 2023	BUY	$62.32 - $89.47 $292,904 - $420,509	4,700 Added 11.23%	46,541 $4 Million
Q3 2022 Nov 10, 2022	SELL	$59.54 - $68.01 $4.98 Million - $5.69 Million	-83,683 Reduced 66.67%	41,841 $2.58 Million
Q2 2020 Aug 11, 2020	SELL	$72.34 - $84.0 $2.17 Million - $2.52 Million	-30,000 Reduced 19.29%	125,524 $9.66 Million
Q1 2020 May 11, 2020	SELL	$62.63 - $80.22 $223,651 - $286,465	-3,571 Reduced 2.24%	155,524 $11.6 Million
Q4 2019 Feb 10, 2020	SELL	$61.62 - $67.78 $970,206 - $1.07 Million	-15,745 Reduced 9.01%	159,095 $10.3 Million
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $1.69 Million - $1.86 Million	27,000 Added 18.26%	174,840 $11.1 Million
Q2 2019 Aug 09, 2019	BUY	$61.87 - $69.38 $122,997 - $137,927	1,988 Added 1.36%	147,840 $9.99 Million
Q1 2019 May 10, 2019	BUY	$62.53 - $70.05 $1.14 Million - $1.27 Million	18,188 Added 14.25%	145,852 $9.48 Million
Q4 2018 Feb 11, 2019	SELL	$60.54 - $79.0 $2.62 Million - $3.42 Million	-43,245 Reduced 25.3%	127,664 $7.99 Million
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $1.67 Million - $1.85 Million	-23,417 Reduced 12.05%	170,909 $13.2 Million
Q2 2018 Aug 09, 2018	BUY	$64.88 - $75.68 $242,456 - $282,816	3,737 Added 1.96%	194,326 $13.8 Million
Q1 2018 May 09, 2018	BUY	$72.84 - $88.8 $92,142 - $112,332	1,265 Added 0.67%	190,589 $14.4 Million
Q4 2017 Feb 12, 2018	SELL	$71.15 - $83.52 $414,804 - $486,921	-5,830 Reduced 2.99%	189,324 $13.6 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $14.1 Million - $16.7 Million	195,154	195,154 $15.8 Million

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

Black Rock Inc. New York, NY

121M
Shares

$10.6 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.2 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.72 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.32 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$5.23 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tredje Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Tredje Ap Fonden with notifications on news.

Account